Capital Analysts LLC Has $199,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Analysts LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 381 shares of the medical equipment provider’s stock after buying an additional 31 shares during the quarter. Capital Analysts LLC’s holdings in Intuitive Surgical were worth $199,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $2,401,493,000. Proficio Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares in the last quarter. Capital Research Global Investors raised its holdings in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on ISRG shares. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Finally, Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $598.95.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now directly owns 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,819 shares of company stock worth $15,937,836 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.1 %

NASDAQ:ISRG opened at $514.01 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The firm has a market capitalization of $183.08 billion, a P/E ratio of 80.19, a P/E/G ratio of 5.85 and a beta of 1.55. The stock’s fifty day simple moving average is $510.03 and its 200-day simple moving average is $533.26.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company earned $1.50 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.